SCHEMBL4508361

SCHEMBL4508361

COc1c(C)c(C(=O)c2ccc(N)c(C(=O)O)c2C)n2cccc(OCC(=O)NCCCCCCCCCCCNC(=O)COc3cccn4c(C(=O)c5ccc(N)c(C(=O)O)c5C)c(C)c(OC)c34)c12

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ PKM P14618 1/20 0.38
▸ CTSD P07339 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.37
▸ PLA2G1B P04054 6/20 0.35
▸ DHODH Q02127 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ KMT2A Q03164 2/20 0.33
▸ POLB P06746 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ HDAC3 O15379 1/20 0.33
▸ HDAC1 Q13547 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ PLA2G10 O15496 1/20 0.33
▸ PLA2G2A P14555 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4496523 0.86 CTSD (0.39) L3MBTL1ALDH1A1PKMCTSDHSD17B10
SCHEMBL4516631 0.83 ALDH1A1 (0.36) ALDH1A1PLA2G1BKMT2AMAPTMEN1
SCHEMBL4508358 0.83 CTSD (0.39) L3MBTL1ALDH1A1PKMCTSDHSD17B10
SCHEMBL13918689 0.75 MAPT (0.38) ALDH1A1HSD17B10PLA2G1BTSHRKMT2A
SCHEMBL4507727 0.72 PLA2G1B (0.40) ALDH1A1CTSDHSD17B10PLA2G1BTSHR
SCHEMBL4502206 0.71 KMT2A (0.40) ALDH1A1PKMHSD17B10KMT2APOLB
SCHEMBL4513946 0.70 MEN1 (0.42) L3MBTL1ALDH1A1PKMHSD17B10PLA2G1B
SCHEMBL13918690 0.69 MEN1 (0.38) ALDH1A1HSD17B10PLA2G1BTSHRKMT2A
SCHEMBL1572906 0.69 DDB1 (0.36) ALDH1A1HSD17B10PLA2G1BKMT2AMAPT
SCHEMBL1573301 0.69 KMT2A (0.38) L3MBTL1ALDH1A1HSD17B10PLA2G1BKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9120819-B2 FGF-receptor agonist dimeric compounds SANOFI (FR) 2015-09-01 — — US disclosed
US-20090069368-A1 FGF-RECEPTOR AGONIST DIMERIC COMPOUNDS SANOFI-AVENTIS (FR) 2009-03-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069368-A1 FGF-RECEPTOR AGONIST DIMERIC COMPOUNDS FGF2, FGFR1, FGF1 L3MBTL1 1353/4885ALDH1A1 1044/4885PKM 2337/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback